crisamicin C

isolated from Micromonospora purpureochromogenes subsp halotolerans; structure given in first source

Also Known As:

CRS-C; 5a,11a-Epoxy-5H-furo(3,2-b)naphtho(2,3-d)pyran-2,6,11(3H)-trione, 8-(3,3a,5,6,11,11b-hexahydro-10-hydroxy-5-methyl-2,6,11-trioxo-2H-furo(3,2-b)naphtho(2,3-d)pyran-8-yl)-3a,11b-dihydro-10-hydroxy-5-methyl-

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Choi, Gil Soon: 1 article (02/2021)
2.	Kim, Chang Hoi: 1 article (02/2021)
3.	Kim, Jooyeon: 1 article (02/2021)
4.	Kwon, Jae Hwan: 1 article (02/2021)
5.	Song, Ji Ah: 1 article (02/2021)
6.	Cao, Shougen: 1 article (05/2018)
7.	Chen, Dong: 1 article (05/2018)
8.	Jiang, Haitao: 1 article (05/2018)
9.	Li, Yu: 1 article (05/2018)
10.	Liu, Xiaodong: 1 article (05/2018)

Related Diseases

1.	Allergic Rhinitis 02/01/2021 - "We divided patients into 4 groups: ENS (group A), chronic rhinosinusitis with polyp (CRS c polyp, group B), chronic rhinosinusitis without polyp (CRS s polyp, group C), and allergic rhinitis (AR, group D). "
2.	Chronic Renal Insufficiency 03/30/2015 - "Among a new wave of urinary biomarkers germane to CRS, C-type natriuretic peptide (CNP) has emerged as an innovative biomarker of renal structural and functional impairment in HF and chronic renal disease states. "
3.	B-Cell Lymphoma (Lymphoma, B Cell) 01/01/2018 - "Western blot analysis showed that QLQX significantly reduced the expressions of AngII, non-phagocytic cell oxidase (NOX)2, and B-cell lymphoma (Bcl)2 associated X protein (Bax), and increased the expressions of Bcl2 and Angiotensin II Type 1 receptor (ATR) in the kidney as compared with the CRS-C group. "
4.	Stomach Neoplasms (Stomach Cancer) 05/25/2018 - "The clinicopathological features and treatment were compared between CRS after benign disease operation (CRS-B) group and CRS after gastric cancer operation (CRS-C) group, and factors influencing prognosis were analyzed using Cox regression model analysis. "
5.	Polyps 02/01/2021 - "We divided patients into 4 groups: ENS (group A), chronic rhinosinusitis with polyp (CRS c polyp, group B), chronic rhinosinusitis without polyp (CRS s polyp, group C), and allergic rhinitis (AR, group D). "

Related Drugs and Biologics

1.	bcl-2-Associated X Protein (bcl 2 Associated X Protein)
2.	Natriuretic Peptides
3.	Type 1 Angiotensin Receptor
4.	Biomarkers (Surrogate Marker)
5.	Oxidoreductases (Dehydrogenase)
6.	crisamicin B